HIMS
Hims is a 100% online telehealth platform focused on men’s wellness, offering clinician-guided assessments and prescription treatments for conditions such as hair loss, erectile dysfunction, weight management, and skin care. The company operates across the United States, providing doctor consultations, medication shipped to customers, and at-home lab testing to personalize treatment plans. With a broad product portfolio and a patient-centric approach, Hims emphasizes discreet, accessible care through an all-online process and a mobile app. Headquartered in San Francisco, it serves millions of subscribers with licensed providers and FDA-regulated pharmacies.
Hims & Hers Expands Personalized Digital Healthcare Platform
Hims & Hers Launches Integrated AI‑Driven Digital Health Platform
Stocks Recover as Oil Retreats From $119: Stock Market Today
Stock Market Week: Nvidia Earnings, Apple And Strategy Events
Dow Hits Record as Retail Sales Stall | Closing Bell
Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B
Market Update: TPR, EQR, CBOE
Novo, Lilly Sputter as Hims Launches Knockoff GLP-1 Pill